Hepatotoxicity Due To Mushroom Poisoning: A Case Report
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 4 No. 2(Spring) (2014),
20 June 2014
,
Page 68-73
https://doi.org/10.22037/ijmtfm.v4i2(Spring).4915
Abstract
Background: Although the majority of mushroom ingestions are benign, some result in significant toxicity and death. Of greatest concern is the hepatotoxic amatoxin-containing mushroom, which may be fatal even small ingestions. Identification of amatoxin poisoning can prove to be difficult due to delay in onset of symptoms and difficulty with identification of mushrooms.
Case Report: We present one case of mushroom ingestion in Kerman, province what according to clinical course and laboratory finding, we believe to be an amanita species, treated with multiple dose of activated charcoal, N-acetylcysteine, high-dose penicillin and liver Gol (silymarin).
Conclusion: We present the successful treatment a patient who ingested hepato-toxicity induced mushrooms, further, this case is evidence of a mushroom variety responsible for toxicity never previously implicated in the southeastern Iran.
- Amanita
- Mushroom Poisoning
- High-Dose Penicillin
- N-AcetylCyctein
- Silymarin
How to Cite
References
Michael W. Shannon, Stephen W. Borron, Michael J. Burns, Haddad and Winchester`s clinical management of poisoning and drag over dose; 4thed: saunders, an imprint of Elsevier inc. 2007;455-61.
Ward J, Kapadia K, Brush E, Steven D. Salhanick MD. Amatoxin Poisoning: Case Reports and review of current therapies. the Journal of Emergency Medicine. 2012;1:1-6.
Trestrail H. Mushroom poisoning in the united states–an analysis of 1989 united states poison center data. Clin Toxicol. 1991;29:459-465.
Magdalane J, Ostrowska A, Podhorska M. Early morphological and functional alterations in canine hepatocytes. Arch toxicol. 2009;83:55-60.
Pajoumand A, Shadnia S, Efricheh H, Mmandegary A , Hassanianmoghadam H, Abdollahi M. A restrospective study of mushroom poisoning in Iran. Hum exp toxicol. 2005;24(12):609-13.
Amini M, Ahmadabadi A, Kazemifar AM, Solhi H, Jand Y, Phalloides A. intoxication Mis diagnosed as acute appendicitis: a case report, Iranian Journal of Toxicology. 2011;5(14):527-530.
Varshochi M, Naghili B. Mushroom poisoning in northwest of Iran. Iranian Journal of Clinical Infections Disease. 2007;2(4):164-175.
Ghodsi K. A 26 years old soldier with hepatic failure due to mushroom poisoning, Shiraz E-Medical Journal. 2002;3(2):37-44.
Keith L, Robert G, Hendrickson B, Zane k. Amanita phalloides poisoning. Clinical Toxicology. 2011;49:128-129.
Hall IR, Stevenson SL, Buchanan PK, Yun W, Cole ALJ. Collecting wild mushrooms. In Edible and poisonous mushrooms of theworld. Cambridge. UK. Timber Press. 2003;43-118.
Burd A, Siggt, Fischbein C. Amanita Virosa poisoning: agent of terrorists or criminal activity? Vet Hum Toxicol. 2003;45:226.
Spoke DG, Rumack BH. Handbook of mushroom poisoning: diagnosis and Treatment. Boca, FL, CRC Press. 1994.
Benjamin Dr: mushrooms: poisons and panaceas. New York, WH Freeman, 1995
Piotrow S, Gomulkiewicz I, Sozanski A, Szelag T, Dzigiel P. Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with alph-amantin. Hum EXP Toxicol. 2011;30:38-43.
Montanini S, Sinardi D, Pratico C. Use of acetyl cysteine as the life-saving antidote in Amina phalloides (death cap) poisoning. Arzneimittel for schung. 1999;99:1044-1047.
Robert S, Hoffman S, Howland M, Neal A, Lewis R. Gold F. Gold frank`s manual of toxicologic emergences 8thed: mc Graw- Hill companies. 2007;876.
Floersheim GL. Experimental basis for the therapy of Amanita phalloides poisoning [german].Schweiz med Wochen Schr. 1978;108:185-97.
Lestschert K, Faul stich H, Keller D. Molecular characterization and inhibition of amanitin uptake human hepatocytes. Toxicol Sci. 2006; 91:140-90.
National center for complementary and alternative medicine milk thistle. Available at:http://nccam.nih.gov/health/milk thistle/ataglance.htm. Accessed February 14 2011.
Enjalbert F, Rapior S, Nouquier-soule J, Gaillon S, Amouroax N, Cabot C. Treatment of amatoxin poisoning : 20 years retrospective analysis. J Toxicol 2002;20:715-57.
Gordon A, Hobb A. Bowden DS. Effects of silybum marianum on serum hepatitis C virus RND alanine aminotrans ferase levels and well-being in patients with chronic hepatitis C. J Gastro Enterol Hepatol. 2006;21:275-80
Schneider SM, Borochovitz D. Hepato toxicity in mice: a potential model for the treatment of Amanita phalloides poisoning .ANN Emerg med. 1987;16:1136-40.
Salhanick SD, Wax PM, Schneider SM. In response to tong TC. comparative treatment of alpha-amanitin poisoning. With N-Acetylcesteine, benzyl penicillin, cimeticline, thiotic acid, and silybin in a murine model. ANN Emerg Med. 2008; 52:184-5.
Mullins M, Horowitz B. The futility of hemo perfusion and hemodialysis in Amanita phalloides poisoning. Vet Hum Toxicol. 2000; 42:40-1.
Jander S, Bischoff J, Woodcock BG. Plasmapharesis in the treatment of Amanita phalloides poisoning: ∏: areview and recommend dations. The Apher. 2000;4:308-12.
- Abstract Viewed: 624 times
- PDF Downloaded: 776 times